Delivery Order SPE2DB24D1021-SPE2DB25FEYNQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Prometrium 100 mg capsules (30-count units) with a ceiling value of $1,051.72. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Prometrium 200 mg capsules (30-count packages) with a contract value of $1,516.55. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $3,209.35 to AmerisourceBergen Drug Corp for the supply of Prometrium 100 mg capsules (30-count units) under a firm fixed price contract. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Prometrium 200 mg capsules (30-count units) under a firm fixed price contract type. The award, valued at $12,604.81, is scheduled for completion by July 31, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform this contract at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Prometrium 100 mg capsules (30-count units) with a ceiling value of $4,241.83. This competitive, non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfills this requirement as a child order under a larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $105,258.40 to AmerisourceBergen Drug Corp for the supply of Prometrium 200 mg capsules (30-count units). This firm fixed-price delivery order was competitively awarded without set-aside provisions and carries an ultimate completion date of August 20, 2025. The award leverages AmerisourceBergen's position as a major pharmaceutical distributor and critical vendor for federal medical procurement, with performance taking place at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,492.65 to AmerisourceBergen Drug Corp for the supply of Prometrium 200 mg capsules (30-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract operates under a firm fixed-price structure with no set-aside designation, indicating competitive award status. Performance will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $13,132.61 to AmerisourceBergen Drug Corp for the supply of Prometrium 200 mg capsules (30-count units) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,492.65 to AmerisourceBergen Drug Corp for the supply of Prometrium 200 mg capsules (30-count units). This competitively awarded, firm fixed-price delivery order, issued on July 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside provisions, with performance...
- The Defense Logistics Agency awarded a delivery order valued at $58,102.85 to AmerisourceBergen Drug Corp for the supply of Prometrium 200 mg capsules (30-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYNQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Prometrium 100 mg capsules (30-count packaging) under a firm fixed-price contract with a ceiling value of $5,113.26. This is a non-set-aside competitive award with an ultimate completion date of July 14, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. Through this prime contract vehicle, the company supplies a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The company's performance on multiple competitively awarded contracts demonstrates its capability to meet federal procurement requirements across varying order sizes and therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 7/11/25 |